Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-01-23
1997-12-16
Chambers, Jasemine C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
4353201, 435 6, 4351723, 435 691, 935 62, 935 55, 935 54, 935 71, 935 34, 935 65, C12N 1563, C12N 1579, C12N 1509, A61K 4800
Patent
active
056985312
ABSTRACT:
A method for the direct treatment towards the specific sites of a disease is disclosed. This method is based on the delivery of proteins by catheterization to discrete blood vessel segments using genetically modified or normal cells or other vector systems. Endothelial cells expressing recombinant therapeutic agent or diagnostic proteins are situated on the walls of the blood vessel or in the tissue perfused by the vessel in a patient. This technique, provides for the transfer of cells or vectors and expression of recombinant genes in vivo and allows the introduction of proteins of therapeutic or diagnostic value for the treatment of diseases.
REFERENCES:
patent: 4332893 (1982-06-01), Rosenberg
patent: 4353888 (1982-10-01), Sefton
patent: 4636195 (1987-01-01), Wolinsky
patent: 4824436 (1989-04-01), Wolinsky
patent: 4874746 (1989-10-01), Antoniades et al.
patent: 5087617 (1992-02-01), Smith
Proc. Natl. Acad. Sci., vol. 84, Nov. 1987, pp. 7413-7417, P.L. Felgner, et al., "Lipofection: A Highly Efficient, Lipid-Mediated DNA-Transfection Procedure".
Science, vol. 249, Sep. 14, 1990, pp. 1285-1288, E.G. Mabel, et al., "Site-Specific Gene Expression In Vivo by Direct Gene Transfer into the Arterial Wall".
Wang et al, Biochemistry (1989), vol. 28 pp. 9508-9514.
Zwiebel, "High-Level Recombinant Gene Expression in Rabbit Endothelial Cells Transduced by Retroviral Vectors", Science, Jan. 1989, vol. 243, pp. 220-222.
Nabel, "Recombinant Gene Expression in vivo Within Endothelial Cells of the Arterial Wall", Science, Jun. 1989, vol. 244, pp. 1342-1344.
Selden, "Implantation of Genetically Engineered Fibroblasts into Mice: Implications for Gene Therapy", Science, May 1987, vol. 236, pp. 714-718.
Tanaka et al, Science, vol. 228, 5 Apr. 1985, pp. 26-30.
Bubenik et al, Immunol. Letters 19 (1988) pp. 279-282.
Cancer Research, vol. 50, pp. 5102-5106, Aug. 15, 1990, M. Ogura, et al., "Implantation of Genetically Manipulated Fibroblasts into Mice as Antitumor Alpha-Interferon Therapy".
Science, vol. 244, Jun. 16, 1989, pp. 1344-1346, J. M. Wilson, et al., "Implantation of Vascular Grafts Lined with Genetically Modified Endothelial Cells".
Federation of American Societies for Experimental Biology, 75th Annual Meeting, Apr. 21-25, 1991, 1 page.
Wolff, et al. "Direct Gene Transfer into Mouse Muscle in Vivo," Science, vol. 247 :465-468, Mar. 23, 1990.
Jon W. Wolff et al, "Direct Gene Transfer into Mouse Muscle In Vivo", Science, vol. 247, pp. 1465-1468, Mar. 28, 1990.
Nabel Elizabeth G.
Nabel Gary J.
Chambers Jasemine C.
Hauda Karen M.
The Regents of the University of Michigan
LandOfFree
Treatment of diseases by site-specific instillation of cells or does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of diseases by site-specific instillation of cells or , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of diseases by site-specific instillation of cells or will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-206090